How can community pharmacists be supported to manage skin conditions? A multistage stakeholder research prioritisation exercise

Jane Harvey *, Zakia Shariff, Claire Anderson, Matthew J. Boyd, Matthew J. Ridd, Miriam Santer, Kim Suzanne Thomas, Ian Maidment, Paul Leighton

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

1 Citation (Scopus)


Objective To establish research priorities which will support the development and delivery of community pharmacy initiatives for the management of skin conditions.

Design An iterative, multistage stakeholder consultation consisting of online survey, participant workshops and prioritisation meeting. 

Setting All data collection took place online with participants completing a survey (delivered via the JISC Online Survey platform, between July 2021 and January 2022) and participating in online workshops and meetings (hosted on Microsoft Teams between April and July 2022). 

Participants 174 community pharmacists and pharmacy staff completed the online survey. 53 participants participated in the exploratory workshops (19 community pharmacists, 4 non-pharmacist members of pharmacy staff and 30 members of the public). 4 healthcare professionals who were unable to attend a workshop participated in a one-to-one interview. 29 participants from the workshops took part in the prioritisation meeting (5 pharmacists/pharmacy staff, 1 other healthcare professional and 23 members of the public). 

Results Five broad areas of potential research need were identified in the online survey: (1) identifying and diagnosing skin conditions; (2) skin conditions in skin of colour; (3) when to refer skin conditions; (4) disease-specific concerns and (5) product-specific concerns. These were explored and refined in the workshops to establish 10 potential areas for research, which will support pharmacists in managing skin conditions. These were ranked in the prioritisation meeting. Among those prioritised were topics which consider how pharmacists work with other healthcare professionals to identify and manage skin conditions. 

Conclusions Survey responses and stakeholder workshops all recognised the potential for community pharmacists to play an active role in the management of common skin conditions. Future research may support this in the generation of resources for pharmacists, in encouraging public take-up of pharmacy services, and in evaluating the most effective provision for dealing with skin conditions.

Original languageEnglish
Article numbere071863
JournalBMJ Open
Issue number1
Publication statusPublished - 2 Jan 2024

Bibliographical note

Funding Information:
JH, IM, CA, KST, PL, ZS have declared they have no conflict of interest. MJB has received personal fees from Delphi Healthcare outside the submitted work, has grants or contracts with Health Education England (Grant for development of experimental learning activity) and Walgreen Boots Alliance (50% funding for PhD studentship). MJB has received consulting fees from Clinical Care Quality Solutions (payment split between institution and author). MJB has received payment from the Ministry of Health Singapore, Human Manpower Development Programme (honoraria to speak including travel and accommodation). MJB is a Project Advisor/Chair of experiential learning during the MPharm research project. NHS Scotland (payment to institution and author). MJB is Vice Chair Pharmacy Law and Ethics Association (no fee received). MS has the following grants or contracts: RAPID and Efficient Eczema Trials (RAPID programme)—lead applicants Thomas and Roberts. NIHR PGfAR NIHR203279 funding to University of Southampton for 5% of my time.Trial of IGe tests for Eczema Relief (TIGER): randomised controlled trial of test-guided dietary advice for children with eczema, with internal pilot and nested economic and process evaluations – lead applicant Ridd. NIHR HTA NIHR133464 funding to University of Southampton for 10% of my time. Pragmatic, primary care, multi-centre, randomised superiority trial of four emollients in children with eczema, with internal pilot and nested qualitative study (Best Emollients for Eczema—BEE)—lead applicant Ridd. NIHR HTA 15/130/07 completed Aug 2020 funding to University of Southampton for 10% of my time. MS is a funding panel member NIHR Programme Grants for Applied Research 2018 to present day and also Academic PPIE lead and Board Member NIHR School for Primary Care Research 2022 to present day. MR has received various NIHR grants for studies of skin conditions/food allergy. MR is on TSC/DMC for ERICA, PRINCIPLE and ALPHA trials and is Co-Chair SAPC & NIHR SPCR skin/allergy research groups.

Funding Information:
This project is funded by the National Institute for Health and Care Research (NIHR) School for Primary Care Research (project reference 522). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.

Publisher Copyright:
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.


  • Patient Participation


Dive into the research topics of 'How can community pharmacists be supported to manage skin conditions? A multistage stakeholder research prioritisation exercise'. Together they form a unique fingerprint.

Cite this